RMD vs SOLS · P/E 29, rev $5.65B vs P/E 71, rev $3.89B
ResMed Inc (RMD) versus Solstice Advanced Materials, Inc (SOLS) — a side-by-side from cached financials, not a winner call.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Solstice Advanced Materials, Inc (SOLS) is a specialty chemicals company listed on NASDAQ.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Latest reported SOLS revenue for 2025-12-31 was $3.89B. Net income was $237.0M. Revenue was up 3.1% from 2024-12-31 to 2025-12-31. SOLS currently screens at market cap $13.51B and trailing P/E 71.5.
RMD currently screens at market cap $37.68B and trailing P/E 28.8. SOLS currently screens at market cap $13.51B and trailing P/E 71.5.
Not investment advice. Open the RMD and SOLS stock pages for the full models.
Not investment advice.